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Abstract
Background: In order to avoid unnecessary use of hospital services at the end-of-life, palliative care should be
initiated early enough in order to have sufficient time to initiate and carry out good quality advance care planning
(ACP). This single center study assesses the impact of the PC decision and its timing on the use of hospital services
at EOL and the place of death.
Methods: A randomly chosen cohort of 992 cancer patients treated in a tertiary hospital between Jan 2013 –Dec
2014, who were deceased by the end of 2014, were selected from the total number of 2737 identified from the
hospital database. The PC decision (the decision to terminate life-prolonging anticancer treatments and focus on
symptom centered palliative care) and use of PC unit services were studied in relation to emergency department
(ED) visits, hospital inpatient days and place of death.
Results: A PC decision was defined for 82% of the patients and 37% visited a PC unit. The earlier the PC decision
was made, the more often patients had an appointment at the PC unit (> 180 days prior to death 72% and < 14
days 10%). The number of ED visits and inpatient days were highest for patients with no PC decision and lowest for
patients with both a PC decision and an PC unit appointment (60 days before death ED visits 1.3 vs 0.8 and
inpatient days 9.9 vs 2.9 respectively, p < 0.01). Patients with no PC decision died more often in secondary/tertiary
hospitals (28% vs. 19% with a PC decision, and 6% with a decision and an appointment to a PC unit).
Conclusions: The PC decision to initiate a palliative goal for the treatment had a distinct impact on the use of
hospital services at the EOL. Contact with a PC unit further increased the likelihood of EOL care at primary care.
Keywords: Palliative care, Cancer, End-of-life care, Hospitalization, Emergency department, Place of death, Advance
care planning, Finland
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Background
Cancer patients are often admitted to hospital care dur-
ing the last months of their life [1]. In some cases, this is
unavoidable, but an increased number of emergency de-
partment (ED) visits, inpatient hospital admissions, or
dying in an acute-care setting is also a characteristic of
insufficient palliative care (PC) for patients with ad-
vanced cancer approaching their end-of-life (EOL) [2, 3].
In contrast, patients receiving in-home PC are less likely
to visit the ED or to be admitted to a hospital than those
receiving standard care [4, 5]. Furthermore, community-
based palliative home-care services are not only associ-
ated with reduced ED visits, but also with fewer and
shorter hospitalizations, lower risk of intensive care unit
(ICU) admission, as well as an increased likelihood of a
home death [6–9].
It has been demonstrated that early integrated PC
leads to less aggressive EOL care, including reduced
chemotherapy and longer hospice care [10]. The longer
the hospice care period the better the quality of life [11].
Early integrated palliative care also reduces the rates of
hospitalization and ED visits [10, 12]. Thus, palliative de-
cision making is preponed.
Internationally, the terminology of the PC period and
its timing and content is somewhat confusing. In the
Lancet Oncology Commission paper [13] the terms are
defined based on the treatment intention: curative, life
prolonging, or palliative. However, PC can be integrated
at any stage of the disease trajectory, irrespective of the
primary intention of the treatment [13]. When the pri-
mary treatment goal is set to palliative, and the disease
modifying treatments end, the period of PC begins. In
our study this moment is called the PC decision.
An earlier transition into PC can be one way of redu-
cing the use of hospital services at the EOL [2, 3]. It
gives more time to initiate and carry out advance care
planning (ACP) including a connection to primary care
or a hospice as well as organizing care in the home, if
possible. ACP is important; although it can be con-
ducted by general practitioners, PC specialists are highly
skilled in this area. Thus, an appointment at a PC unit
may offer one approach for improving the quality and
completion of the ACP documentation [14]. Conse-
quently, the service needs of the patients at the EOL
should be addressed outside both the ED and the sec-
ondary or tertiary care hospital. The site of death may
then indicate the quality of end-of-life care, as the ma-
jority of patients with the serious illness want to die at
home rather than in an institutional setting [11].
Although there are studies showing that an earlier
introduction (of one to more than three months prior to
death) of PC is associated with improved EOL care, in
terms of fewer hospitalizations and increased likelihood
of dying at home or in a hospice [15–18], there is no
data, to our knowledge, regarding the impact of the tran-
sition from life-prolonging anticancer treatments to PC
and its timing on the hospitalizations and site of death
in cancer patients.
In our earlier study [19], we reported that PC decisions
done within the last month prior to death were associ-
ated with anti-cancer treatments continuing until close
to death, and the access to a PC unit becoming more
unlikely. Therefore, a well-timed decision to initiate a
palliative period might also be related to more appropri-
ate treatment and resource usage at the EOL.
The aim of this study was to evaluate whether the PC
decision and a referral to a PC unit have an impact on




This cohort consists of a sample of patients with a cancer
diagnosis (ICD-10 C00-C96) who had received treatment
in the Department of Oncology at Helsinki University
Central Hospital (HUCH) between January 1 –December
31, 2013 and were deceased by December 31, 2014. The
total number of patients fulfilling the criteria was 2 737
and of these, 992 were randomly selected for the study co-
hort from the hospital register. Randomization was done
by sorting the patients in the order of their pseudony-
mized identifier, creating a random order. Finally 949 pa-
tients were included; 43 patients with non-malignant
primary cause of death or pediatric patients were ex-
cluded. This retrospective study was done with the per-
mission of the authorities of HUCH. According to Finnish
legislation, no ethics committee approval was needed.
Finnish cancer patients are treated mainly at public
university and central hospitals. HUCH is the largest
university hospital in Finland being responsible for the
cancer care of a population of approximately 1.6 million
in Southern Finland. HUCH is governed by the repre-
sentatives of all the municipalities in the region and
HUCH provides all secondary and tertiary care for these
municipalities. During the time of this study, the HUCH
Department of Oncology provided radiation therapy
treatments for all cancer patients and systemic cancer
treatments for most cancer patients (not for pediatric (<
18 years), hematological, gynecological or lung cancer
patients). There is a PC outpatient unit in the Depart-
ment of Oncology, but municipalities, who in Finland
organize primary care, are responsible for EOL care.
However, early integrated PC was not systematically pro-
vided at HUCH at the time of the study.
Data sources and collection
The data and data sources used in the study are the
same as in [19], but some new variables were considered
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in addition to those in [19]: do not resuscitate (DNR) de-
cisions, visits to the ED in secondary/tertiary hospitals,
inpatient episodes in secondary/tertiary hospitals, ap-
pointments to PC units, timing of the PC decision, and
the date and place of death. Most data used in this study
was available in a structured format and exported dir-
ectly from the electronic medical records. Information
on the PC decision, DNR decision and place of death
were manually extracted by two of the authors (LH and
OH). Due to the nature of the data, there were no miss-
ing values as it is mandatory to record all the parameters
used. The only missing or imprecise information was in
the death certificates concerning the place of death (3%).
The cancer diagnoses were grouped in the same way
as in [19] into 13 groups. When the patient had more
than one malignancy, the cancer diagnosis was recorded
to match the primary cause of death.
Division of categories and service usage
The service usage of all patients was studied 14, 30, and
60 days before the time of death. Service usage is enu-
merated by two measures, the number of visits to an
emergency department (‘ED visits’) and the number of
nights spent in the hospital (‘inpatient days’). The places
of death were categorized in five categories: home, pri-
mary care wards, secondary or tertiary care wards, hos-
pices, and nursing homes. In the 24 municipalities of
Southern Finland, at the time of the study, there was
one hospice, one PC ward in primary care and seven
home care teams specialized in PC.
The PC decision and the PC period are defined as in
[19]. For the purposes of this study patients were divided
into three separate categories: ‘no PC decision’, ‘PC deci-
sion’, and ‘PC decision and appointment to a PC unit’.
This definition is operated in a dynamic fashion in the
analyses to ensure a correct chronology of events. For
example, if patients have a PC decision made 40 days
prior to death and have visited the PC unit 20 days be-
fore death, they will be categorized as ‘PC decision’ for
the analysis of events 30 days prior to death, and as ‘PC
decision and appointment to a PC unit’ for the analysis
of events 14 days prior to death. However, when consid-
ering service usage 60 days prior to death, they will be
categorized as ‘no PC decision’, as at that time neither
the PC decision nor the appointment have taken place.
Thus, in each analysis, the patients were categorized de-
pending on the timing of the PC decision and PC unit
appointment with respect to the time period studied.
Statistical analysis
Means, standard deviations, and distributions were used
for patient characteristics. The frequency of DNR deci-
sions and the distribution of the places of death were
analyzed by cross-tabulation. Pairwise Pearson’s chi
squared tests were conducted to statistically test for the
differences between the three categories with respect to
DNR and place of death. The difference between the
three categories with respect to ED and inpatient service
usage was tested with pairwise t-tests (pooled standard
deviation and p-values adjusted with the Holm method).
The association of the PC decision and PC unit appoint-
ments with hospital service usage was also tested with
linear regression models including control variables (age,
time from diagnosis to death, and cancer diagnosis).
Logarithmic transformations for the dependent and inde-
pendent variables were conducted to normalize the resid-
uals in the regression models. All analyses were performed
using R-studio version 1.1.447 and its packages.
Results
Characteristics of the patients are presented in Table 1.
For most patients (82%) a PC decision was made, and
37% of the patients had an appointment at the PC unit.
The frequency of DNR decisions in the ‘No PC decision
at all’ category is statistically significantly smaller than in
the ‘PC decision at some point’ category (p< 0.01), as is
the frequency of DNR decisions in the ‘PC decision and
appointment to a PC unit at some point’ category when
compared to the ‘PC decision at some point’ category
(p<0.05). However, the differences in the frequency of
DNR decisions is not statistically significant between the
‘No PC decision at all’ and the ‘PC decision and appoint-
ment to a PC unit at some point’ categories. The pair-
wise comparisons of the distributions of the places of
death between the three patient categories are all statis-
tically significant (p<0.01).
Place of death
The association of the PC decision and the PC unit
appointment with the place of death is also presented in
Table 1. The significant difference between the categor-
ies is that patients with no PC decision died more often
in secondary/tertiary care wards (28% vs. 19% and 6%,
respectively) whereas patients with a PC decision or both
a PC decision and a PC unit appointment were more
likely to die in primary care wards (46% vs. 56% and
59%, respectively).
Resource use
Table 2 describes the timing of the PC decision with re-
spect to the time of death, and the proportion of patients
visiting the PC unit. The earlier the PC decision was
made, the more often patients also visited the PC unit.
Figures 1 and 2 depict the average resource usage of
the three categories of patients in the hospital ED and
inpatient wards 14, 30 and 60 days prior to death. The
average number of ED visits (Fig. 1) and the average
number of inpatient days (Fig. 2) were highest for
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patients with no PC decision and lowest for patients
with both a PC decision and a visit to a PC unit.
The results of the regression models are presented in
Table 3. The models confirm the negative association
between the PC decision and service usage prior to
death, as well as between PC unit appointments and ser-
vice usage prior to death, even after considering poten-
tial control variables, such as age and cancer site. On
average, patients with a PC decision and an appointment
to a PC unit had 15-24% less ED visits and 56-64% fewer
inpatient days than the patients without a PC decision.
Discussion
In this assessment of the treatment of cancer patients at
a Finnish university hospital, a PC decision to initiate a
palliative intention for the treatment decreased the num-
ber of ED visits and inpatient days in a secondary/ter-
tiary care hospital. Patients without a PC decision also
died more often in a secondary or tertiary care hospital
compared to the patients with a PC decision. The usage
of health care services was further decreased if the pa-
tient had an appointment to a PC outpatient unit in
addition to a PC decision.
Table 1 Characteristics of the patients
Category
Measure No PC decision at all PC decision at some point PC decision and appointment
to a PC unit at some point
Total
Number of patients, N (%) 176 (19%) 424 (45%) 349 (37%) 949 (100%)
Gender, N (%)
Male 86 (49%) 225 (53%) 188 (54%) 499 (53%)
Female 90 (51%) 199 (47%) 161 (46%) 450 (47%)
Age (years) at death, mean (Stdev) 64 (11.9) 67 (11.8) 68 (12.5) 67 (12.1)
Cancer diagnoses, N (%)
Upper gastrointestinal 29 (16%) 83 (20%) 106 (30%) 218 (23%)
Colorectal cancers 17 (10%) 52 (12%) 54 (15%) 123 (13%)
Lung * 27 (15%) 75 (18%) 16 (5%) 118 (12%)
Breast cancer 24 (14%) 53 (13%) 29 (8%) 106 (11%)
Prostate cancers 13 (7%) 19 (4%) 35 (10%) 67 (7%)
Cancers of urinary tract 6 (3%) 29 (7%) 26 (7%) 61 (6%)
Primary CNS malignancies 16 (9%) 30 (7%) 14 (4%) 60 (6%)
Lymphomas 6 (3%) 20 (5%) 11 (3%) 37 (4%)
Invasive skin cancers 6 (3%) 17 (4%) 9 (3%) 32 (3%)
Sarcomas 5 (3%) 10 (2%) 15 (4%) 30 (3%)
Gynecological cancers * 9 (5%) 8 (2%) 11 (3%) 28 (3%)
Head & Neck (H&N) 8 (5%) 12 (3%) 8 (2%) 28 (3%)
Others 10 (6%) 16 (4%) 15 (4%) 41 (4%)
Time (months) from diagnosis to death, mean (Stdev) 33 (44) 37 (43) 41 (46) 37 (44)
DNR decision made, N (% of category) 77 (44%)a,c 240 (57%)a,b 171 (49%)b,c 488 (51%)
Place of death, N (%)
Home 26 (15%) 37 (9%) 73 (21%) 136 (14%)
Hospice 10 (6%) 53 (13%) 31 (9%) 94 (10%)
Nursing home 3 (2%) 9 (2%) 7 (2%) 19 (2%)
Primary care ward 81 (46%)d 236 (56%)d 205 (59%)d 522 (55%)
Secondary / tertiary healthcare 50 (28%)d 80 (19%)d 22 (6%)d 152 (16%)
Unknown 6 (3%) 9 (2%) 11 (3%) 26 (3%)
* only patients receiving radiotherapy are included
a The difference between these groups is statistically significant (p < 0.01)
b The difference between these groups is statistically significant (p < 0.05)
c The difference between these groups is not statistically significant (p > 0.05)
d The pairwise differences between these groups are statistically significant (p < 0.01)
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These results give an indication that a PC decision and
an appointment to a PC outpatient unit may improve
the quality of EOL care. However, it must be kept in
mind that this conclusion applies on an aggregate level;
on the individual level ED visits and hospitalizations
may still be very well justified.
Internationally, the terminology of the PC period and
its timing and content are not uniform. We chose to div-
ide patients according to the timing of PC decisions and
service usage by using time periods before death on clin-
ical grounds and thus complying with most of the previ-
ous studies; however, the lack of strict recommendations
on this timing makes comparison between previous
studies and the present study somewhat difficult. Re-
garding the timing of the PC initiation, in two previous
studies [15, 17] early PC referral was defined as a referral
to PC ≥30 days, whereas in the study by Alsirafy and co-
workers [16] the timing of PC referrals were categorized
as early (> 90 days before death), intermediate (30-90
days before death) and late (<30 days before death). In
the study by Nieder and co-workers [18], three months
before death was chosen as a time point to distinguish
between an early and late PC. However, the timing of
the PC period should be considered together with the
content of the PC period, that is, whether patients re-
ceived only treatments managing symptoms, or also
disease-modifying treatments. These studies have not
made a distinction between the patients receiving early
integrated PC (during the active oncologic treatments),
or late PC (after discontinuation of active oncologic
treatments). No systematic early integrated PC was
offered at HUCH during the time period of this study,
although early integration has since been recommended
by the clinical practice guidelines of the American
Society of Clinical Oncology (ASCO), as well as the
Lancet Commission of integration of oncology and PC
[13, 20]. Therefore, our cohort only represents PC intro-
duced after the termination of anti-cancer treatments;
Table 2 Timing of the palliative care decision and the
proportion of patients visiting a PC unit (%)
Time between the PC
decision and death
All patients with PC decision




N (% patients with
PC decision within
the timeframe)
< 14 days 171 (22%) 17 (10%)
14–30 days 141 (18%) 50 (35%)
31–90 days 206 (27%) 105 (51%)
91–180 days 113 (15%) 75 (66%)
> 180 days 142 (18%) 102 (72%)
Fig. 1 Mean number of emergency department visits 14, 30, and 60 days before the death of patients with no PC decision, with a PC decision
and with both a PC decision and visit to a PC unit before the time frame under consideration. Standard errors of the mean in parentheses. * The
pairwise comparison of the mean number of inpatient days is statistically significant (p < 0.05) ** The pairwise comparison of the mean number
of inpatient days is statistically significant (p < 0.01)
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although the current evidence and recommendations
highlight the importance of providing PC early and inte-
grating it with disease modifying therapies. It is due to
this limitation and the fact that most of the PC decisions
were made quite close to death (for 67 % of patients
who had a PC decision, it was made within the last 3
months of life) that we chose to study the effect of the
PC decision and the PC unit appointment with binary
(yes/no) variables. This approach loses some information
compared to an approach using the exact time lags be-
tween the PC decision and PC unit appointment and
death in the statistical modeling. However, using this ap-
proach meant that the results were more robust and
statistical significance could be detected.
We have earlier demonstrated with this same cohort
of patients [19] that a PC decision initiating the palliative
goal for care was frequently made, but occurred late
[11]: the median time from the PC decision to death was
46 days. Patients with no or a very late PC decision (<30
days) received more aggressive cancer treatments at the
EOL and made fewer visits to the PC unit. Only 37% of
these patients visited the PC unit. In this study, we fur-
ther show that patients with no or very late PC decision
not only receive more aggressive treatments at the EOL
but also use more hospital services and have a higher
risk of dying in an acute-care setting. These are often
considered to be indicators of a poor quality of end of
life care [21].
Despite the introduction of PC only after discontinu-
ation of active oncological treatments in our cohort, we
did observe the benefit of PC decisions in reducing the
ED visits and inpatient days in the hospital, especially
during the last months of life. A referral to the PC out-
patient unit further decreased the ED visits and inpatient
days. The reduction in the average number of inpatient
days per patient was significant (5-7 days per patient).
The reduction in the average number of ED visits per
patient was 0.3 – 0.5 visits. Even a small reduction in
the number of ED visits, however, is significant in eco-
nomic terms: for this study population it would mean
approximately 200 fewer ED visits during the last month
of life. In addition, we believe that every unnecessary
visit to an ED during the last weeks of life are burden-
some for the patient. However, the coefficients of deter-
mination (adjusted R2) of the regression models are
relatively low – especially in the model for ED visits –
indicating that there is considerable variation in the data
that this model does not capture. A systematic review
and meta-analysis has indicated that PC services de-
crease the likelihood of ED visits [3]. An earlier study of
cancer patients in Finland also showed that a visit to the
PC outpatient clinic facilitated the connection with
Fig. 2 Mean number of inpatient days 14, 30, and 60 days before the death of patients with no PC decision, with a PC decision and with both a
PC decision and a visit to a PC unit before the time frame under consideration. Standard errors of the mean in parentheses. * The pairwise
comparison of the mean number of inpatient days is statistically significant (p < 0.05) ** The pairwise comparison of the mean number of
inpatient days is statistically significant (p < 0.01)
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primary care services and tended to decrease ED visits
and resource usage of the tertiary care hospital [14].
Both these earlier studies are in line with our results.
We suggest that although a switch to a palliative goal for
care may modify the EOL care arrangements of a pa-
tient, a sufficiently early contact with the PC services
might have an even higher impact [10].
Early PC (initiated > 1 to > 3 months prior to death
depending on the study) has been shown to be associ-
ated with fewer hospitalizations, earlier DNR designa-
tion, and an increased likelihood of dying at home or in
a hospice instead of a hospital or an ICU [15–18]. In line
with the previous studies, in our study, patients without
a PC decision and especially those without any contact
to the PC unit were more likely to die in a secondary or
tertiary hospital ward. However, in the present study,
the majority of the patients died in a primary care ward
as there were only a few hospices or wards specializing
in EOL care available during that time. Likewise, dying
at home was rare due to the lack of specialized palliative
home care teams.
Patients dying of cancer use the resources of hospitals
- often for a good reason – but any reduction in the
utilization of hospital wards is also beneficial from an
economic perspective [22]. Indeed, it has been shown
that palliative home care support or a proactive PC pro-
gram reduces hospital use and the total costs of care at
the EOL [9, 23]. We did not carry out a cost benefit ana-
lysis in this study, but this important aspect warrants in-
vestigation in future studies.
There are some limitations to our study. One limita-
tion is that the study was conducted on a random sam-
ple of the entire cohort. However, the sample of about
1000 patients was considered large enough to detect sta-
tistically significant differences between the patient
groups, as this ensured that there would be over 100 pa-
tients in all the categories that were critical for the study
(the number of patients with no PC decision, and
Table 3 Results of the regression model expressed as the proportional change (%) in the patients’ services usage 14, 30 and 60 days
prior to death resulting from an increase in the covariates by 1 %. In the case of binary variables, the coefficient depicts the
proportional changed in the service in each diagnosis group compared to breast cancer patients
Dependent variable
Emergency department visits Inpatient days
Number of days before death 14 30 60 14 30 60
Age − 0.2a − 0.1 − 0.2b −0.3 − 0.1 −0.4b
Days from diagnosis to death 0.0 0.0 0.0 0.0 −0.1 − 0.1
Binary variable: Diagnosis groups (reference category: Breast cancer)
Cancers of urinary tract −0.4 1.0 20.2b 9.2 25.8 42.7
Colorectal cancers 4.0 7.9 9.1 −5.1 16.9 10.4
Gynecological cancers 3.2 −1.6 −8.7 1.3 11.7 25.9
Head & Neck (H&N) −10.2 − 16.7 − 18.5 −30.6 −29.8 − 8.1
Lung 8.7 10.8 7.9 9.0 12.8 13.2
Lymphomas −1.9 2.0 5.7 50.8b 60.3b 64.2b
Melanoma and other skin cancers −0.6 −4.9 −7.9 −24.1 − 26.2 −23.8
Others −0.6 5.8 5.3 33.4 81.9a 89.6a
Primary CNS malignancies −11.7b −17.8a −22.1a −44.1a −38.1a −39.4a
Prostate cancers 6.6 10.3 13.6 7.6 12.2 15.4
Sarcomas −11.7 −19.2b −19.7 − 32.7 −24.7 −25.6
Upper gastrointestinal 6.8 8.7 12.2 5.1 22.1 20.6
Binary variable: PC categories (reference category: ‘no PC decision’)
PC-decision −12a −18.6a −13.4a −47.1a −57.6a −51.1a
PC-decision and admission to PC unit −15.3a −21.9a −24.2a −56a −63.4a −64.4a
Test statistics
Adjusted R2 0.06 0.08 0.06 0.13 0.18 0.16
F-stat 4.45 6.13 4.98 10.16 14.16 12.02
Residual standard error 0.35 0.44 0.53 1.10 1.08 1.14
aSignificant at 0.01, bSignificant at 0.05
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patients with PC decision and an appointment to the PC
unit). A random sample was chosen instead of the entire
cohort because the manual collection of data from un-
structured texts in medical records and death certificates
proved so time-consuming that we would have needed
more than two experts for the data collection. We con-
sidered the division of data collection among several ex-
perts to be a risk for the homogeneity of the data, and
therefore chose to proceed with a sample.
In addition, the results do not contain the number of
ED visits or inpatient days in primary care services since
this information is not in the hospital databases. Fur-
thermore, we could not exclude the possibility of some
sudden deaths or deaths due to complications in the sec-
ondary or tertiary hospital; however, according to previ-
ous studies this would explain only a small proportion of
deaths [24]. The lack of data on the quality of life is also
a limitation. Finally, the analysis exploits the “benefit of
hindsight” where the date of death is known. Thus, mak-
ing recommendations on this basis for the future care of
living patients is not possible without existing accurate
prognostication as a part of clinical practice. The
strength of the study is a relatively large sample size.
The study cohort represent a population-based real-life
situation comparable to epidemiological incidence of
oncological diseases found within the population.
The retrospective chart review is one of the most reli-
able forms of research into PC and associated outcomes,
due to the very high recruitment rate: once the approach
is set and agreed, the desired number of cases can be
gathered with very few exceptions.
Conclusions
Our study revealed that although for most cancer pa-
tients a PC decision (i.e. the decision to alter the treat-
ment goal to palliative) was made for less than half of
the patients, the decisions made were in collaboration
with a PC team. The lack of a PC decision or postponing
it to the last weeks of life reflected a significantly in-
creased risk of visits to an ED, more inpatient days in a
secondary or tertiary care hospital, and further, dying in
a secondary or tertiary care ward. Early integrated PC
should be offered more systematically to ensure a timely
ACP and access to palliative and EOL care.
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